secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K/A
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0000950170-24-032821
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney finalizes separation agreement with ex-CEO Bertram; $620K severance plus benefits
--------------------------------------------------------------------------------

- Company pays $620K severance, bonus up to 60% of base salary for 2023 based on scorecard.
- COBRA/Medicare premiums paid 100% through May 31, 2025; legal fees reimbursed up to $20K.
- Vested stock options exercisable for 90 days after effective date; unvested equity forfeited.
- Vested Class B ordinary shares remain subject to lockup until July 11, 2026 or regulatory milestone.
- Standard release, non-disparagement, cooperation, and continuing obligations included.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024032821/0000950170-24-032821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024032821/prok-20231110.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-032821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer